Sort
17,828 grants matching “crispr”
Role of Gadd45b in Cocaine-driven Epigenetic and Behavioral Dynamics
$639,695Jeremy J Day · University Of Alabama At Birmingham · R01 · FY2025 · DA
Role of Gadd45b in Cocaine-driven Epigenetic and Behavioral Dynamics
$639,695Jeremy J Day · University Of Alabama At Birmingham · R01 · FY2023 · DA
Role of Gadd45b in Cocaine-driven Epigenetic and Behavioral Dynamics
$639,695Jeremy J Day · University Of Alabama At Birmingham · R01 · FY2024 · DA
Multimodal approach investigating the immunomodulatory effect ofneural stem cells in stroke recovery
$639,541Gary K Steinberg · Stanford University · R01 · FY2019 · NS
FEN1 Endonuclease as a Synthetic Lethal Target for Cancer Therapy
$639,488Richard D Kolodner · University Of California, San Diego · R01 · FY2025 · CA
FEN1 Endonuclease as a Synthetic Lethal Target for Cancer Therapy
$639,488Richard D Kolodner · University Of California, San Diego · R01 · FY2021 · CA
Project 3: Regulatory RNAs as Cancer Drivers and Dependencies
$639,360David L Spector · Cold Spring Harbor Laboratory · P01 · FY2025 · CA
Project 3: Regulatory RNAs as Cancer Drivers and Dependencies
$639,360David L Spector · Cold Spring Harbor Laboratory · P01 · FY2023 · CA
Aberrant Micro-managing of the Airway Epithelial Transcriptome in HIV-associated COPD
$639,342Hoshang Jehangir Unwalla · Florida International University · R01 · FY2025 · HL
Project 2: Investigating cell intrinsic and extrinsic drivers of prostate cancer bone metastasis
$639,074Cory Abate-Shen · Columbia University Health Sciences · P01 · FY2022 · CA
Project #2 - Banchereau
$639,003Maria Virginia Pascual · Weill Medical Coll Of Cornell Univ · P50 · FY2022 · AR
Bioprinting 3D skin for patient-specific drug discovery in inflammatory skin diseases.
$638,800Angela M Christiano · Columbia University Health Sciences · U18 · FY2018 · TR
Genetic epidemiology of rare and regulatory variants for metabolic traits
$638,741Karen L Mohlke · Univ Of North Carolina Chapel Hill · R01 · FY2024 · DK
ASPH Targeted Therapy for Chondrosarcoma
$638,644Richard M Terek · Rhode Island Hospital · R01 · FY2023 · CA
Characterization and targeting of the epigenetic state underlying uveal melanoma liver metastasis
$638,640Keiran Smalley · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · CA
Reverse Engineering of Cell Senescence
$638,421Marc W Kirschner · Harvard Medical School · R01 · FY2022 · AG
Characterization and targeting of the epigenetic state underlying uveal melanoma liver metastasis
$638,384Keiran Smalley · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA
Beyond Gene Dosage: Understanding Down Syndrome via 4D Genome Organization
$638,318Wenbo Li · University Of Texas Hlth Sci Ctr Houston · U01 · FY2020 · HL
Mechanisms and therapeutic implications of human clonal hematopoiesis (CH) mutations
$638,281Eirini Papapetrou · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA
Epigenomic Reprogramming in Patient Derived Models of Colorectal Cancer
$638,270Xiling Shen · Duke University · U01 · FY2018 · CA
MELT: Modulation of PSMA Expression for Lutetium Therapy
$638,248Thomas Hope · University Of California, San Francisco · R01 · FY2022 · CA
Implementing genomic medicine in clinical care of deaf patients
$638,090Xue Z Liu · University Of Miami School Of Medicine · R01 · FY2020 · DC
Mechanism of Gdf3 action to limit insulin sensitivity in obesity
$638,001Alexander Banks · Beth Israel Deaconess Medical Center · R01 · FY2022 · DK
Mechanism of Gdf3 action to limit insulin sensitivity in obesity
$638,001Alexander Banks · Beth Israel Deaconess Medical Center · R01 · FY2023 · DK
Genetic architecture of host response to tickborne disease in Peromyscus leucopus
$637,988Anthony Douglas Long · University Of California-Irvine · R01 · FY2023 · AI